Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XRNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.350.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.254NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.418NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.122NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAJNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.431NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.168NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.6 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.59NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.177.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.277NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.28 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.272NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.371NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.353NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.407NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.182NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.218NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.12.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.22 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.128NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.36.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.405NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.296NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.412NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.421NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.364NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.82NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.251NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used